A detailed history of Virtu Financial LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 32,000 shares of DCTH stock, worth $320,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
32,000
Holding current value
$320,000
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$7.36 - $11.0 $235,520 - $352,000
32,000 New
32,000 $289,000
Q2 2023

Jul 27, 2023

BUY
$5.38 - $7.96 $58,754 - $86,931
10,921 New
10,921 $64,000
Q1 2022

May 17, 2022

SELL
$5.64 - $7.95 $83,308 - $117,429
-14,771 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$7.2 - $11.72 $106,351 - $173,116
14,771 New
14,771 $114,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $86M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.